Cargando…

Long-term cardiovascular adverse events in very elderly COVID-19 patients

Detalles Bibliográficos
Autores principales:	Karadavut, Serhat, Altintop, Ismail
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783397/ https://www.ncbi.nlm.nih.gov/pubmed/35091302 http://dx.doi.org/10.1016/j.archger.2022.104628

Ejemplares similares

The Effectiveness and Adverse Events of Amitriptyline and Aripiprazole in Very Elderly Patients With BMS
por: Watanabe, Motoko, et al.
Publicado: (2022)

Adverse Drug Events and Associated Factors in Heart Failure Therapy Among the Very Elderly
por: Sztramko, Richard, et al.
Publicado: (2011)

Long-term risk of major adverse cardiovascular events following ischemic stroke or TIA
por: Carlsson, Andreas, et al.
Publicado: (2023)

Echocardiographic Parameters Predict Short- and Long-Term Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction
por: Han, Meng-Meng, et al.
Publicado: (2021)

The Triglyceride-Glucose Index Can Predict Long-Term Major Adverse Cardiovascular Events in Turkish Patients With High Cardiovascular Risk
por: Hayıroğlu, Mert İlker, et al.
Publicado: (2022)

Cardiovascular events after COVID-19 hospitalization: long-term follow-up
por: Negreira-Caamaño, Martín, et al.
Publicado: (2022)

Is Blood Pressure Lowering in the Very Elderly With Previous Stroke Associated With a Higher Risk of Adverse Events?
por: Tharmaratnam, Damien, et al.
Publicado: (2021)

Cardiovascular Adverse Events Associated with Monoclonal Antibody Products in Patients with COVID-19
por: Zou, Jingrui, et al.
Publicado: (2022)

Impact of Vaccination on Major Adverse Cardiovascular Events in Patients With COVID-19 Infection
por: Jiang, Joy, et al.
Publicado: (2023)

IMPACT OF VACCINATION ON MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG PATIENTS WITH COVID-19
por: Jiang, Joy, et al.
Publicado: (2023)

Patients with Very High Risk of Cardiovascular Adverse Events during Carfilzomib Therapy: Prevention and Management of Events in a Single Center Experience
por: Mingrone, Giulia, et al.
Publicado: (2023)

Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control
por: Hsu, Chiao-Po, et al.
Publicado: (2014)

Carotid Endarterectomy in the Very Elderly: Short-, Medium-, and Long-Term Outcomes
por: Fahad, Shabin, et al.
Publicado: (2023)

Classic cardiovascular risk factors improve in very elderly hypopituitary patients treated on standard hormone replacement in long term follow- up
por: Rosa, Isabella Naves, et al.
Publicado: (2021)

Long-Term Survival and Adverse Events in Cardiac Sarcoidosis
por: Kupari, Markku, et al.
Publicado: (2022)

Long‐Term Blood Pressure Variability and Major Adverse Cardiovascular and Cerebrovascular Events After Intracerebral Hemorrhage
por: Castello, Juan Pablo, et al.
Publicado: (2022)

ATRIAL FIBRILLATION AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG HOSPITALIZED COVID-19 PATIENTS
por: Aten, Kristopher, et al.
Publicado: (2022)

Mortality and Major Adverse Cardiovascular Events in Hospitalized Patients With Atrial Fibrillation With COVID-19
por: Wang, Lucas, et al.
Publicado: (2023)

Long‐Term Visit‐to‐Visit Glycemic Variability as a Predictor of Major Adverse Limb and Cardiovascular Events in Patients With Diabetes
por: Hsu, Jung‐Chi, et al.
Publicado: (2023)

Immune Thrombocytopenia in a Very Elderly Patient With Covid-19
por: Hindilerden, Fehmi, et al.
Publicado: (2020)

Effects of Renin‐Angiotensin–Aldosterone System Inhibitors on Long‐Term Major Adverse Cardiovascular Events in Sepsis Survivors
por: Ou, Shu‐Yu, et al.
Publicado: (2021)

Necroptosis Drives Major Adverse Cardiovascular Events During Severe COVID-19
por: Wiscovitch-Russo, Rosana, et al.
Publicado: (2023)

Major adverse cardiovascular events are associated with necroptosis during severe COVID-19
por: Wiscovitch-Russo, Rosana, et al.
Publicado: (2023)

Reply: Long-Term Survival and Adverse Events in Cardiac Sarcoidosis
por: Kusano, Kengo, et al.
Publicado: (2022)

Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis
por: Charles‐Schoeman, Christina, et al.
Publicado: (2019)

PPI Long Term Use: Risk of Neurological Adverse Events?
por: Novotny, Michal, et al.
Publicado: (2019)

Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease
por: Tessitore, Elena, et al.
Publicado: (2021)

TROPONIN-I PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS AND RISK OF MORTALITY IN COVID-19 PATIENTS
por: Patel, Chirag, et al.
Publicado: (2021)

Improvement of long-term clinical outcomes by successful PCI in the very elderly women with ACS
por: Wang, Jia-li, et al.
Publicado: (2021)

Long-term cardiovascular outcomes of COVID-19
por: Xie, Yan, et al.
Publicado: (2022)

Association of Selected Antipsychotic Agents With Major Adverse Cardiovascular Events and Noncardiovascular Mortality in Elderly Persons
por: Sahlberg, Marie, et al.
Publicado: (2015)

Novel Insight Into Long-Term Risk of Major Adverse Cardiovascular and Cerebrovascular Events Following Lower Extremity Arteriosclerosis Obliterans
por: Sun, Ji, et al.
Publicado: (2022)

Long-term major adverse cardiovascular events following myocardial injury after non-cardiac surgery: meta-analysis
por: Strickland, Scarlett S, et al.
Publicado: (2023)

Increased long-term risk of major adverse cardiovascular events in patients with carbon monoxide poisoning: A population-based study in Taiwan
por: Wong, Chung-Shun, et al.
Publicado: (2017)

A prognostic nomogram for long-term major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention
por: Kong, Shuting, et al.
Publicado: (2021)

Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19
por: Cutler, Michael J., et al.
Publicado: (2022)

Patient characteristics and acute cardiovascular event rates among patients with very high‐risk and non‐very high‐risk atherosclerotic cardiovascular disease
por: Fonarow, Gregg C., et al.
Publicado: (2021)

Adverse Drug Events in the Elderly: An Ongoing Problem
por: Gray, Charnelda, et al.
Publicado: (2009)

Endoscopic Resection of Ampullary Tumours: Long-term Outcomes and Adverse Events
por: Alali, Ali, et al.
Publicado: (2019)

Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS)
por: Zhao, Ying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0pa6hpdp9v2bscllb1kj842pr5